62024CO0181_SUM
Case C‑181/24
Genmab A/S
v
Szellemi Tulajdon Nemzeti Hivatala
(Request for a preliminary ruling from the Fővárosi Törvényszék)
Order of the Court (Eighth Chamber) of 16 July 2024
(Reference for a preliminary ruling – Article 99 of the Rules of Procedure of the Court of Justice – Medicinal product for human use – Supplementary protection certificate for medicinal products (SPC) – Regulation (EC) No 469/2009 – Conditions for granting – Article 3(d) – First marketing authorisation (MA) – Medicinal products containing the same active ingredient being granted several MAs – Withdrawal of the prior MA)
Approximation of laws – Uniform legislation – Industrial and commercial property – Patent right – Supplementary protection certificate for medicinal products – Conditions for granting – First marketing authorisation for the product as a medicinal product – Concept – Marketing authorisation in force on the date of lodging the application for a supplementary protection certificate – Existence of a prior authorisation granted for that same product, withdrawn before the application for the supplementary protection certification was submitted – Precluded
(European Parliament and Council Regulation No 469/2009, Art. 3(d))
(see paragraphs 25-33, operative part)
See the text of the decision.